FINISHED DOSAGE FORMULATIONS
Drug : KETEK
Dosage Form : TABLET; ORAL
Application Number : 21144
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; IRBESARTAN
Drug : AVALIDE
Dosage Form : TABLET; ORAL
Application Number : 20758
Country : US
Patented : No
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
Drug : NAMENDA
Dosage Form : TABLET; ORAL
Application Number : 21487
Country : US
Patented : No
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Drug : VICODIN
Dosage Form : TABLET; ORAL
Application Number : 88058
Country : US
Patented : No
Drug : LEXAPRO
Dosage Form : TABLET; ORAL
Application Number : 21323
Country : US
Patented : No
Drug : CELEXA
Dosage Form : TABLET; ORAL
Application Number : 20822
Country : US
Patented : No
Drug : MAVIK
Dosage Form : TABLET; ORAL
Application Number : 20528
Country : US
Patented : No
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50698
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Application : Disintegrants & Superdisintegrants
Excipient Details : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.
Pharmacopoeia Ref : IP/BP/EP/USP-NF
Technical Specs : Sallyso 0.5 to 3.0%
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Application : Disintegrants & Superdisintegrants
Excipient Details : It is used as a disintegrating agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Disolcel® GF
Ingredient(s) : Croscarmellose Sodium
Brand Name : Croscarmellose Sodium
Application : Disintegrants & Superdisintegrants
Excipient Details : Tablet and capsule disintegrant.
Pharmacopoeia Ref : USP/BP/EP/CP
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Application : Granulation
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
MARKET PLACE
Reply
17 Sep 2024
Reply
24 Aug 2023
Reply
14 Jun 2023
Reply
29 May 2023
Reply
16 Jun 2022
Reply
07 Jan 2022
Reply
17 Dec 2021
Reply
20 Jul 2021
Reply
31 Oct 2020
Reply
06 May 2019
REF. STANDARDS & IMPURITIES
LOOKING FOR A SUPPLIER?